BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17895242)

  • 1. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling.
    Weng Z; Signore AP; Gao Y; Wang S; Zhang F; Hastings T; Yin XM; Chen J
    J Biol Chem; 2007 Nov; 282(47):34479-91. PubMed ID: 17895242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK.
    Ugarte SD; Lin E; Klann E; Zigmond MJ; Perez RG
    J Neurosci Res; 2003 Jul; 73(1):105-12. PubMed ID: 12815714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease.
    Latchoumycandane C; Anantharam V; Jin H; Kanthasamy A; Kanthasamy A
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):314-23. PubMed ID: 21846476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
    Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
    Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells.
    Chalovich EM; Zhu JH; Caltagarone J; Bowser R; Chu CT
    J Biol Chem; 2006 Jun; 281(26):17870-81. PubMed ID: 16621793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway.
    Li Q; Li S; Fang J; Yang C; Zhao X; Wang Q; Zhou W; Zheng W
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The octadecaneuropeptide ODN prevents 6-hydroxydopamine-induced apoptosis of cerebellar granule neurons through a PKC-MAPK-dependent pathway.
    Kaddour H; Hamdi Y; Vaudry D; Basille M; Desrues L; Leprince J; Castel H; Vaudry H; Tonon MC; Amri M; Masmoudi-Kouki O
    J Neurochem; 2013 May; 125(4):620-33. PubMed ID: 23286644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells.
    Lin E; Cavanaugh JE; Leak RK; Perez RG; Zigmond MJ
    J Neurosci Res; 2008 Jan; 86(1):108-17. PubMed ID: 17847117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via Akt and ERK signaling pathways.
    Ge KL; Chen WF; Xie JX; Wong MS
    J Ethnopharmacol; 2010 Jan; 127(1):118-23. PubMed ID: 19799986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra.
    Li LY; Zhao XL; Fei XF; Gu ZL; Qin ZH; Liang ZQ
    Acta Pharmacol Sin; 2008 May; 29(5):539-47. PubMed ID: 18430361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons.
    Choi WS; Eom DS; Han BS; Kim WK; Han BH; Choi EJ; Oh TH; Markelonis GJ; Cho JW; Oh YJ
    J Biol Chem; 2004 May; 279(19):20451-60. PubMed ID: 14993216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells.
    Lee HJ; Noh YH; Lee DY; Kim YS; Kim KY; Chung YH; Lee WB; Kim SS
    Eur J Cell Biol; 2005 Nov; 84(11):897-905. PubMed ID: 16323286
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Martins IK; de Carvalho NR; Macedo GE; Rodrigues NR; Ziech CC; Vinadé L; Filho VMB; Menezes IA; Franco J; Posser T
    Oxid Med Cell Longev; 2018; 2018():2131895. PubMed ID: 30510616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of cyclic AMP-ERK-Bad signaling pathways on 6-hydroxydopamine-induced cell survival and death in PC12 cells.
    Park HJ; Park KH; Shin KS; Lee MK
    Toxicol In Vitro; 2013 Dec; 27(8):2233-41. PubMed ID: 24055892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pinocembrin-7-Methylether Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Neurotoxicity via Modulating Nrf2 Induction Through AKT and ERK Pathways.
    Zou ZC; Fu JJ; Dang YY; Zhang Q; Wang XF; Chen HB; Jia XJ; Lee SM; Li CW
    Neurotox Res; 2021 Aug; 39(4):1323-1337. PubMed ID: 33999357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Ecdysterone Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Apoptosis via Mitochondria-Dependent Mechanism: Involvement of p38(MAPK)-p53 Signaling Pathway.
    Pan Z; Niu Y; Liang Y; Zhang X; Dong M
    Neurotox Res; 2016 Oct; 30(3):453-66. PubMed ID: 27229883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
    Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
    J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.